Company intelligence / Profile preview

Auden Mckenzie

Castleford, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Auden Mckenzie was a leading UK developer and marketer of generic pharmaceuticals and proprietary medicines, specifically noted for its hydrocortisone tablets. The company's conduct and pricing practices around its hydrocortisone product led to multiple competition and market abuse findings and fines.

Therapeutic areas: Endocrinology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Auden Mckenzie.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Auden Mckenzie.

Explore the full profile